Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01204372
What this trial is testing

Trial Evaluating Combined Chemotherapy in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 63
Not applicableLooking for participantsNCT07190677
What this trial is testing

First-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Fondazione IRCCS Policlinico San Matteo di Pavia 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Testing effectiveness (Phase 2)Study completedNCT03723967
What this trial is testing

FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Centre Leon Berard 104
Not applicableStudy completedNCT01185639
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaLiver CancerAdrenal Cancer
Wake Forest University Health Sciences 29
Not applicableUnknownNCT02002195
What this trial is testing

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
International Group of Endovascular Oncology 47
Not applicableUnknownNCT06034964
What this trial is testing

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC

Who this might be right for
TislelizumabChemotherapyFirst-line+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT02954536
What this trial is testing

Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00428714
What this trial is testing

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Who this might be right for
Prostate Cancer
Eli Lilly and Company 73
Not applicableStudy completedNCT02821949
What this trial is testing

Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy

Who this might be right for
Non Small Cells Lung Cancer
Centre Hospitalier Universitaire, Amiens 45
Large-scale testing (Phase 3)Ended earlyNCT04786964
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

Who this might be right for
Metastatic Non-squamous Non Small Cell Lung Cancer
Checkpoint Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07481058
What this trial is testing

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT04263298
What this trial is testing

Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Herui Yao 210
Testing effectiveness (Phase 2)Study completedNCT00094809
What this trial is testing

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Who this might be right for
Colon CancerColorectal CancerRectal Cancer
Amgen 252
Testing effectiveness (Phase 2)Looking for participantsNCT04834544
What this trial is testing

Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

Who this might be right for
Epithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Peking University Third Hospital 75
Testing effectiveness (Phase 2)Study completedNCT02608073
What this trial is testing

Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Hoffmann-La Roche 45
Large-scale testing (Phase 3)Looking for participantsNCT06498479
What this trial is testing

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Hansoh BioMedical R&D Company 460
Testing effectiveness (Phase 2)Looking for participantsNCT06367088
What this trial is testing

Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple-negative Breast CancerCadonilimab
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Testing effectiveness (Phase 2)UnknownNCT02098954
What this trial is testing

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

Who this might be right for
Carcinoma, Non-Small Cell LungEGFR Gene Mutation
Hunan Province Tumor Hospital 40
Not applicableLooking for participantsNCT06087783
What this trial is testing

PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy

Who this might be right for
Gynecologic Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 50
Next Page